BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35215988)

  • 21. HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion.
    Mesquita M; Fintelman-Rodrigues N; Sacramento CQ; Abrantes JL; Costa E; Temerozo JR; Siqueira MM; Bou-Habib DC; Souza TM
    PLoS One; 2014; 9(6):e101056. PubMed ID: 24978204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced replication capacity of influenza A(H1N1)pdm09 virus during the 2010-2011 winter season in Tottori, Japan.
    Tsuneki A; Itagaki A; Tsuchie H; Tokuhara M; Okada T; Narai S; Kasagi M; Tanaka K; Kageyama S
    J Med Virol; 2013 Nov; 85(11):1871-7. PubMed ID: 23983181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract.
    Essaidi-Laziosi M; Alvarez C; Puhach O; Sattonnet-Roche P; Torriani G; Tapparel C; Kaiser L; Eckerle I
    Emerg Microbes Infect; 2022 Dec; 11(1):412-423. PubMed ID: 34931581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2009 pandemic influenza A(H1N1) coincides with changes in the epidemiology of other viral pathogens causing acute respiratory tract infections in children.
    Gröndahl B; Ankermann T; von Bismarck P; Rockahr S; Kowalzik F; Gehring S; Meyer C; Knuf M; Puppe W
    Infection; 2014 Apr; 42(2):303-8. PubMed ID: 24150959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.
    Stölting H; Baillon L; Frise R; Bonner K; Hewitt RJ; Molyneaux PL; Gore ML; ; Barclay WS; Saglani S; Lloyd CM
    Mucosal Immunol; 2022 May; 15(5):952-963. PubMed ID: 35840680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation.
    Chan RW; Yuen KM; Yu WC; Ho CC; Nicholls JM; Peiris JS; Chan MC
    PLoS One; 2010 Jan; 5(1):e8713. PubMed ID: 20090947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
    Sourimant J; Lieber CM; Aggarwal M; Cox RM; Wolf JD; Yoon JJ; Toots M; Ye C; Sticher Z; Kolykhalov AA; Martinez-Sobrido L; Bluemling GR; Natchus MG; Painter GR; Plemper RK
    Science; 2022 Jan; 375(6577):161-167. PubMed ID: 34855509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
    Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
    BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral Potential of Azelastine against Major Respiratory Viruses.
    Fischhuber K; Bánki Z; Kimpel J; Kragl N; Rössler A; Bolze A; Muellauer B; Angerer J; Nagy G; Nagy E; Szijarto V
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.
    Elderfield RA; Watson SJ; Godlee A; Adamson WE; Thompson CI; Dunning J; Fernandez-Alonso M; Blumenkrantz D; Hussell T; ; Zambon M; Openshaw P; Kellam P; Barclay WS
    J Virol; 2014 Nov; 88(22):13269-83. PubMed ID: 25210166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
    Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M
    J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells.
    Masaki T; Kojima T; Okabayashi T; Ogasawara N; Ohkuni T; Obata K; Takasawa A; Murata M; Tanaka S; Hirakawa S; Fuchimoto J; Ninomiya T; Fujii N; Tsutsumi H; Himi T; Sawada N
    Mol Biol Cell; 2011 Jul; 22(13):2144-56. PubMed ID: 21562222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
    Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
    PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.
    Tripp RA; Martin DE
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-dependent viral interference between influenza virus and coronavirus in the infection of differentiated porcine airway epithelial cells.
    Peng JY; Shin DL; Li G; Wu NH; Herrler G
    Virulence; 2021 Dec; 12(1):1111-1121. PubMed ID: 34034617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells.
    Smet A; Catani JPP; Ysenbaert T; Gonçalves A; Kleanthous H; Vogel TU; Saelens X; Job ER
    PLoS One; 2022; 17(1):e0262873. PubMed ID: 35100294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A (H1N1) and Respiratory Syncytial Virus (RSV) Coinfection in a Newborn Child: A Case Report.
    Pawlus B; Żukowska J; Nitsch-Osuch A
    Adv Exp Med Biol; 2021; 1324():29-34. PubMed ID: 33346902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.
    Bao L; Deng W; Qi F; Lv Q; Song Z; Liu J; Gao H; Wei Q; Yu P; Xu Y; Qu Y; Li F; Xue J; Gong S; Liu M; Wang G; Wang S; Zhao B; Cong B; Qin C
    Signal Transduct Target Ther; 2021 May; 6(1):200. PubMed ID: 34016949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneously ultrasensitive and quantitative detection of influenza A virus, SARS-CoV-2, and respiratory syncytial virus via multichannel magnetic SERS-based lateral flow immunoassay.
    Liu Z; Wang C; Zheng S; Yang X; Han H; Dai Y; Xiao R
    Nanomedicine; 2023 Jan; 47():102624. PubMed ID: 36328340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.